Edition:
United Kingdom

Indoco Remedies Ltd (INRM.NS)

INRM.NS on National Stock Exchange of India

167.30INR
13 Sep 2019
Change (% chg)

Rs7.05 (+4.40%)
Prev Close
Rs160.25
Open
Rs159.05
Day's High
Rs184.30
Day's Low
Rs150.60
Volume
202,747
Avg. Vol
37,750
52-wk High
Rs238.70
52-wk Low
Rs133.15

Latest Key Developments (Source: Significant Developments)

Indoco Remedies Says UK-MHRA Reinstates Full GMP Status For Goa Plant
Friday, 13 Sep 2019 

Sept 13 (Reuters) - Indoco Remedies Ltd ::UK-MHRA REINSTATES FULL GMP STATUS FOR INDOCO'S GOA PLANT I.UK-MHRA AUDITS WERE COMPLETED WITH NO CRITICAL OBSERVATIONS.  Full Article

India's Indoco Remedies Posts June Qtr Consol Net Profit
Tuesday, 13 Aug 2019 

Aug 13 (Reuters) - Indoco Remedies Ltd ::JUNE QUARTER CONSOL NET PROFIT 18.5 MILLION RUPEES VERSUS LOSS 121.9 MILLION RUPEES YEAR AGO.  Full Article

Indoco Remedies's Goa Plant Gets Warning Letter From USFDA
Monday, 15 Jul 2019 

July 15 (Reuters) - Indoco Remedies Ltd ::INDOCO'S GOA PLANT I RECEIVES WARNING LETTER FROM USFDA.THERE ARE FOUR PENDING ANDAS FROM FACILITY, APPROVALS MAY BE WITHHELD TILL ALL THE ISSUES ARE RESOLVED.  Full Article

India's Indoco Remedies March-Qtr Profit Falls
Wednesday, 29 May 2019 

May 29 (Reuters) - Indoco Remedies Ltd ::MARCH QUARTER PROFIT 116.3 MILLION RUPEES VERSUS 205 MILLION RUPEES YEAR AGO.MARCH QUARTER REVENUE FROM OPERATIONS 2.45 BILLION RUPEES VERSUS 2.59 BILLION RUPEES YEAR AGO.  Full Article

Indoco Remedies Says New Solid Dosages Facility At Baddi Gets UK-MHRA Approval
Wednesday, 8 May 2019 

May 8 (Reuters) - Indoco Remedies Ltd ::SAYS NEW SOLID DOSAGES FACILITY AT BADDI RECEIVES UK-MHRA APPROVAL.  Full Article

Indoco Remedies Says USFDA retains OAI status of Co's Goa Plant 1
Wednesday, 24 Apr 2019 

April 24 (Reuters) - Indoco Remedies Ltd ::UNITED STATES FOOD AND DRUG ADMINISTRATION (USFDA) RETAINS THE OFFICIAL ACTION INDICATED (OAI) STATUS FOR GOA PLANT- I.FACILITY WAS INSPECTED BY THE USFDA IN JANUARY 2019.OAI STATUS WILL NOT IMPACT CO'S CURRENT COMMERCIAL SUPPLIES TO USA OR REVENUES FROM THE MANUFACTURING FACILITY.OAI STATUS MAY WITHHOLD APPROVAL OF CO'S PENDING ANDAS FROM FACILITY.  Full Article

Indoco Remedies Says FDA Re-Inspection Of Goa Plant-I Commences
Friday, 18 Jan 2019 

Jan 18 (Reuters) - Indoco Remedies Ltd ::SAYS FDA RE-INSPECTION OF GOA PLANT-II COMPLETED AND PLANT-I COMMENCED.  Full Article

India's Indoco Remedies March-Qtr Profit Rises
Wednesday, 30 May 2018 

May 30 (Reuters) - Indoco Remedies Ltd ::MARCH QUARTER PROFIT 205 MILLION RUPEES VERSUS PROFIT 179.4 MILLION RUPEES YEAR AGO.MARCH QUARTER REVENUE FROM OPERATIONS 2.59 BILLION RUPEES VERSUS 2.66 BILLION RUPEES YEAR AGO.RECOMMENDED FINAL DIVIDEND OF 1 RUPEE PER SHARE.  Full Article

Indoco Remedies Says API Plant At Patalganga Cleared FDA Inspection With 3 Observations
Friday, 18 May 2018 

May 18 (Reuters) - Indoco Remedies Ltd ::SUCCESSFUL COMPLETION OF USFDA INSPECTION AT API MANUFACTURING FACILITIES AT PATALGANGA AND RABALE, NAVI MUMBAI..SAYS KILO LAB FACILITY RECEIVED ZERO FORM 483 FROM AGENCY.SAYS API PLANT AT PATALGANGA CLEARED INSPECTION WITH 3 OBSERVATIONS.SAYS NONE OF OBSERVATIONS AT PATALGANGA ARE CRITICAL OR PERTAIN TO DATA INTEGRITY.  Full Article

India's Indoco Remedies Gets 3 Critical Observations From UK-MHRA For Goa Facility
Tuesday, 27 Mar 2018 

March 27 (Reuters) - Indoco Remedies Ltd ::UNITED KINGDOM - MEDICINES AND HEALTHCARE PRODUCTS REGULATORY AGENCY (UK-MHRA) INSPECTED CO'S GOA DRUG MANUFACTURING FACILITY.INSPECTION TOOK PLACE BETWEEN MARCH 14 TO MARCH 16.UK-MHRA ISSUED OBSERVATIONS, WHICH INCLUDE 3 CRITICAL AND 4 MAJOR.  Full Article

No consensus analysis data available.